| International real-world study of DLL3 expression in patients with small cell lung cancer F Rojo, M Corassa, D Mavroudis, AB Öz, B Biesma, L Brcic, P Pauwels, ... Lung Cancer 147, 237-243, 2020 | 42 | 2020 |
| Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study S Pant, M Schuler, G Iyer, O Witt, T Doi, S Qin, J Tabernero, DA Reardon, ... The Lancet Oncology 24 (8), 925-935, 2023 | 35 | 2023 |
| Tumor agnostic efficacy and safety of erdafitinib in patients (pts) with advanced solid tumors with prespecified fibroblast growth factor receptor alterations (FGFRalt) in … Y Loriot, MH Schuler, G Iyer, O Witt, T Doi, S Qin, J Tabernero, ... Journal of Clinical Oncology 40 (16_suppl), 3007-3007, 2022 | 33 | 2022 |
| Evaluation of incidence, significance, and prognostic role of circulating tumor microemboli and transforming growth factor‐β receptor I in head and neck cancer MF Fanelli, TB Oliveira, AC Braun, M Corassa, EA Abdallah, UR Nicolau, ... Head & neck 39 (11), 2283-2292, 2017 | 33 | 2017 |
| Circulating tumor cells as cancer biomarkers in the clinic LTD Chinen, EA Abdallah, AC Braun, BCTCP Flores, M Corassa, ... Isolation and Molecular Characterization of Circulating Tumor Cells, 1-41, 2017 | 29 | 2017 |
| EGFR expression in circulating tumor cells from high-grade metastatic soft tissue sarcomas AC Braun, CAL de Mello, M Corassa, EA Abdallah, AC Urvanegia, ... Cancer Biology & Therapy 19 (6), 454-460, 2018 | 22 | 2018 |
| STK11 and KEAP1 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic value among Hispanics (STRIKE registry-CLICaP) VCC de Lima, M Corassa, E Saldanha, H Freitas, O Arrieta, L Raez, ... Lung Cancer 170, 114-121, 2022 | 21 | 2022 |
| Lung cancer in never smokers: Tumor immunology and challenges for immunotherapy VTL de Alencar, AB Figueiredo, M Corassa, KJ Gollob, ... Frontiers in Immunology 13, 984349, 2022 | 18 | 2022 |
| Mutational portrait of lung adenocarcinoma in Brazilian patients: past, present, and future of molecular profiling in the clinic HC Freitas, GT Torrezan, IW Cunha, MP Macedo, V Karen de Sá, ... Frontiers in Oncology 10, 1068, 2020 | 12 | 2020 |
| Thoracic splenosis as a differential diagnosis of juxtapleural nodules B Lopes, LR Almeida, AA Vicente, DC Marcellos, M Corassa, RF Romano, ... Respiratory Medicine Case Reports 11, 1-3, 2014 | 10 | 2014 |
| Comparison of enzalutamide versus abiraterone in castration-resistant prostate cancer before docetaxel: Results of a propensity score-matched analysis. MG Cesca, MT Silveira, NC Pandolfi, TB Oliveira, JA Rinck, ... Journal of Clinical Oncology 37 (15_suppl), e16540-e16540, 2019 | 4 | 2019 |
| Characteristics and outcomes of thymomas in L atin A merica: Results from over 10 years of experience (CLICaP‐LATimus) C Martín, D Enrico, L Mas, AK Patane, O Arrieta, T Soria, AF Cardona, ... Thoracic cancer 12 (9), 1328-1335, 2021 | 3 | 2021 |
| Determination of inter-observer agreement in the immunohistochemical interpretation of PD-L1 clones 22C3 and SP142 in triple-negative breast cancer (TNBC) R Abreu, R Peixoto, M Corassa, W Nunes, T Neotti, T Rodrigues, ... Virchows Archiv 481 (SUPPL 1), S68-S69, 2022 | 2 | 2022 |
| Extensive portal and superior mesenteric vein thrombosis after splenectomy in a patient with hereditary spherocytosis B Lopes, L Almeida, A Vicente, D Marcellos, M Corassa, F Freire, ... Journal of Hematology 2 (2), 79-84, 2013 | 2 | 2013 |
| Outcomes of patients with metastatic neuroendocrine lung neoplasms: typical versus atypical carcinoids H Tanaka, MP Corassa, H Freitas, M Barros, R Riechelmann Brazilian Journal of Oncology 17, 1-6, 2021 | 1 | 2021 |
| P1. 10 Survival of Thymoma Is Extensive in Latin-American Patients: Results from over 10 Years of Experience (CLICaP-LATimus) L Mas, AK Patane, O Arrieta, T Soria, AF Cardona, C Martín, ... Journal of Thoracic Oncology 14 (11), S1177-S1178, 2019 | 1 | 2019 |
| Real-world comparison of the impact of adjuvant capecitabine in women with high-risk triple-negative breast cancer after neoadjuvant chemotherapy MTS Vilbert, MP Corassa, RR Saleh, RL Coelho, M Teixeira, E Amir Annals of Oncology 30, v70, 2019 | 1 | 2019 |
| Circulating tumor cells as a new and additional approach to follow-up patients with serous low-grade ovarian adenocarcinoma–a case report and review of the literature M Corassa, APG Guimarães, SM Sanches, MF Fanelli, BMM Rocha, ... Applied Cancer Research 37, 1-6, 2017 | 1 | 2017 |
| Analysis of predictive clinical markers of outcome in patients with metastatic clear-cell renal cell carcinoma (mRCC) treated with tyrosine-kinases inhibitors (TKI) in first … CNM Ferreira, JA Rinck, CSM Albuquerque, TV Costa, ACM Urvanegia, ... Journal of Clinical Oncology 35 (6_suppl), 525-525, 2017 | 1 | 2017 |
| Circulating tumor microemboli as a prognostic factor for locally advanced or metastatic solid tumors. M Corassa, MF Fanelli, TB Oliveira, CL Mello, MC Machado Netto, ... Journal of Clinical Oncology 34 (15_suppl), e23067-e23067, 2016 | 1 | 2016 |
Vladmir Cláudio Cordeiro de LimaOncologista ClínicoVerified email at accamargo.org.br
